Brief: Chinook Therapeutics Announces Formation Of Sanreno Therapeutics, A Joint Venture To Develop Kidney Disease Therapies In China
30/11/2021 13:13
Nov 30 (Reuters) - Chinook Therapeutics Inc KDNY.O :
* CHINOOK THERAPEUTICS ANNOUNCES FORMATION OF SANRENO
THERAPEUTICS, A JOINT VENTURE TO DEVELOP KIDNEY DISEASE
THERAPIES IN CHINA
* CHINOOK THERAPEUTICS INC - GRANTED SANRENO EXCLUSIVE
RIGHTS TO
DEVELOP, COMMERCIALIZE ATRASENTAN & BION-1301 IN TERRITORY FOR
50% OWNERSHIP OF SANRENO
Source text for Eikon: ID:nGNX5BPH
Further company coverage: KDNY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chinook Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Chinook Therapeutics
Chinook Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Chinook Therapeutics Inc expected to post a loss of 81 cents a share - Earnings Preview
Brief: Chinook Therapeutics Announces First Patient Enrolled In Phase 3 Of Zigakibart
Brief: Muddy Waters- Remains Short On Chinook Therapeutics Inc